Technical Analysis for QTRX - Quanterix Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
23.75 | -8.55% | -2.22 |
QTRX closed down 8.55 percent on Wednesday, September 18, 2019, on 1.12 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Sep 27
*** please verify all earnings dates ***| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| See historical QTRX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.00% | |
| 20 DMA Resistance | Bearish | -8.55% | |
| 200 DMA Support | Bullish | -8.55% | |
| 200 DMA Support | Bullish | -6.39% | |
| Fell Below 20 DMA | Bearish | -8.55% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -8.55% | |
| Inside Day | Range Contraction | -8.55% | |
| Crossed Above 20 DMA | Bullish | -10.00% | |
| MACD Bullish Signal Line Cross | Bullish | -10.00% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
Biotechnology Healthcare Life Sciences Biology Disease Inflammation Infectious Disease Biomarkers
Biotechnology Healthcare Life Sciences Biology Disease Inflammation Infectious Disease Biomarkers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more QTRX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 36.15 |
| 52 Week Low | 16.0 |
| Average Volume | 189,839 |
| 200-Day Moving Average | 24.8303 |
| 50-Day Moving Average | 28.1314 |
| 20-Day Moving Average | 25.8225 |
| 10-Day Moving Average | 25.074 |
| Average True Range | 1.6556 |
| ADX | 27.28 |
| +DI | 16.4612 |
| -DI | 29.397 |
| Chandelier Exit (Long, 3 ATRs ) | 23.1632 |
| Chandelier Exit (Short, 3 ATRs ) | 27.0668 |
| Upper Bollinger Band | 28.1292 |
| Lower Bollinger Band | 23.5158 |
| Percent B (%b) | 0.05 |
| BandWidth | 17.865815 |
| MACD Line | -0.8182 |
| MACD Signal Line | -0.8795 |
| MACD Histogram | 0.0613 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 27.56 | ||||
| Resistance 3 (R3) | 27.94 | 27.04 | 26.93 | ||
| Resistance 2 (R2) | 27.04 | 26.07 | 26.86 | 26.71 | |
| Resistance 1 (R1) | 25.40 | 25.47 | 24.95 | 25.02 | 26.50 |
| Pivot Point | 24.50 | 24.50 | 24.28 | 24.32 | 24.50 |
| Support 1 (S1) | 22.86 | 23.53 | 22.41 | 22.48 | 21.00 |
| Support 2 (S2) | 21.96 | 22.93 | 21.78 | 20.79 | |
| Support 3 (S3) | 20.32 | 21.96 | 20.58 | ||
| Support 4 (S4) | 19.94 |
